Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Deoxyribonucleic acid (DNA) and other polyanionic nucleic acids are the primary carriers of genetic information, essential for the replication, growth, and function of all known living organisms and many viruses [NIH, 2023]. In a therapeutic context, these molecules are targeted by a wide array of pharmacological agents, particularly in the treatment of cancer and infectious diseases, where disrupting the integrity of the genetic template can halt uncontrolled cell division [PubChem, 2024]. Common mechanisms of action include DNA alkylation, where drugs form covalent bonds with nucleic acid bases, and intercalation, where planar molecules slide between base pairs to disrupt the double helix structure [StatPearls, 2023]. Additionally, antimetabolites can be incorporated into the growing DNA or RNA strand, leading to chain termination or the production of non-functional genetic material [PubMed, 2022]. Because these targets are fundamental to all dividing cells, drugs that interact with DNA often exhibit significant side effects, such as bone marrow suppression and potential secondary malignancies [Wikipedia, 2024]. Recent advancements also focus on the polyanionic nature of nucleic acids to develop targeted delivery systems for gene therapies and antisense oligonucleotides [Nature, 2023].
DNA alkylation, intercalation, covalent cross-linking, and inhibition of synthesis or repair through antimetabolite incorporation
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyribonucleic acid (DNA) and other polyanionic nucleic acids (DNA/RNA).